Table 1

Univariate analyses of predictors of recurrent ischaemic events

No ischaemic events
(n=1416)
Ischaemic events
(n=104)
P value
Age (median, IQR)78 (17)76 (18)0.179
Sex (% women)706 (49.9)56 (53.8)0.477
Hypertension (%)1175/1415 (83.0)82 (78.8)0.282
Diabetes (%)474/1414 (33.5)36 (34.6)0.830
Hyperlipidamia (%)795/1415 (56.2)58 (55.8)1.000
Prior stroke or TIA (%) 435/1415 (30.7)41 (39.4)0.079
Active smoking (%)170/1414 (12.0)13 (12.5)0.876
Congestive heart failure (%)346/1393 (24.8)25 (24.0)0.907
Coronary artery disease (%)440/1415 (31.1)36 (34.6)0.446
Peripheral vascular disease (%)93/1414 (6.6)7 (6.7)0.840
CHA2DS2-vasc score (median, IQR)5 (3)5 (3)0.215
AF type paroxysmal (%)687/1337 (51.4)49/94 (52.1)0.915
Home anticoagulation (%)502/1414 (35.5)44 (42.3)0.170
Systolic blood pressure (median, IQR)148 (34)152 (37)0.275
Diastolic blood pressure (median, IQR)80 (22)80 (21)0.929
NIHSS score (median, IQR)8 (12)8 (12)0.767
Glucose (median, IQR)121 (45)125 (41)0.609
LDL (median, IQR)77 (44)78 (33)0.951
Positive troponin (%)151/1094 (13.8)14/80 (17.5)0.403
Alteplase (%)412/1416 (29.1)25 (24.0)0.313
Thrombectomy (%)358/1416 (25.2)27 (25.9)0.907
Ischaemic stroke ≥10 mL (%)770/1308 (58.9)57/95 (60.0)0.914
Cardiac thrombus (%)18/1336 (1.3)1/95 (1.1)1.000
Moderate to severe mitral stenosis (%)23/1337 (1.7)3/95 (3.2)0.246
Severe left atrial enlargement (%)437/1154 (37.9)31/78 (39.7)0.810
Left atrial volume (median, IQR)75 (41)72 (47)0.971
Ipsilateral atherosclerosis 50% or more (%)221/1389 (15.9)24 (23.1)0.073
Ejection fraction (median, IQR)59 (15)60 (11)0.652
Anticoagulation initiated (%)1213/1412 (85.9)87 (83.7)0.562
Time to initiating anticoagulation (median, IQR)4 (8)3 (8)0.358
  • AF, atrial fibrillation; LDL, low-density lipoprotein.